GlassScriptPhysician profile
Troy D Espiritu
NPI 1780775791
$5,751.64
in general payments reported to CMS, 2019-2025
37 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $422 · 2021: $406 · 2022: $485 · 2023: $2,099 · 2024: $777 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525 · Travel and Lodging: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.56 |
| Travel and Lodging | $784.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,599.94 | 2019-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Affinity |
| Cgg Medical INC | $1,003.42 | 2023 | |
| Arthrex, INC. | $621.16 | 2023 | |
| Horizon Therapeutics Plc | $611.04 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $262.14 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Amgen INC. | $177.56 | 2024-2025 | Krystexxa |
| Pfizer INC. | $146.85 | 2019-2020 | |
| Polynovo North America LLC | $127.17 | 2024 | Novosorb Btm |
| Averitas Pharma INC. | $101.89 | 2023 | Qutenza |
| Zyla Life Sciences, INC. | $92.38 | 2019 | |
| Convatec INC. | $77.59 | 2023 | |
| Paratek Pharmaceuticals, INC. | $65.15 | 2022-2024 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $60.91 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $59.77 | 2022-2023 | Seglentis |
| Bioventus LLC | $59.01 | 2022-2024 | Exogen Ultrasound Bone Healing System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $56.57 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polarityte, INC. | $54.77 | 2019 | |
| Nevro Corp. | $49.17 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $48.46 | 2023 | Kimyrsa |
| Osteomed LLC | $47.25 | 2020 | |
| Grt US Holding, INC. | $45.10 | 2022 | |
| Medtronic, INC. | $43.52 | 2023-2024 | Venaseal |
| Wright Medical Technology, INC. | $39.91 | 2020 | |
| Stryker Corporation | $35.82 | 2020 | |
| Kci USA, INC. | $32.43 | 2020 | |
| Ani Pharmaceuticals, INC. | $24.43 | 2025 | Purified Cortrophin Gel |
| Solventum Corporation | $24.22 | 2024 | Activ.A.C. |
| Next Science LLC | $22.42 | 2022 | |
| Biowound Solutions, INC. | $22.38 | 2025 | Bio-Connekt |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.62 | 2020 | |
| Assertio Therapeutics, INC. | $21.13 | 2020 | |
| Dynasplint Systems INC. | $19.22 | 2025 | Dynasplint |
| Integra Lifesciences Corporation | $18.26 | 2020 | |
| Acera Surgical, INC. | $17.03 | 2024 | Restrata Wound Matrix |
| Abbott Laboratories | $16.53 | 2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $15.39 | 2021 | |
| Orthofix Medical, INC. | $10.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Espiritu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.